Ensign Peak Advisors, Inc
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1454984
SALT LAKE CITY, UT
Position in TEVA
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,230,402
-$231,786 QoQ
Shares Held
40,850
-12.8% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Ensign Peak Advisors, Inc holds $59,723,780 across 18 Drug Manufacturers - Specialty & Generic names. TEVA ranks #5 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
181,481 | $23,908,306 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
25,292 | $14,997,650 | |
| 3 | ZTS |
Zoetis Inc.
|
108,357 | $12,808,880 | |
| 4 | BIOA |
BioAge Labs, Inc.
|
166,224 | $2,907,257 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
40,850 | $1,230,402 | |
| 6 | VTRS |
Viatris Inc
|
65,686 | $887,417 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
31,510 | $754,034 | |
| 8 | PBH |
Prestige Consumer Healthcare Inc.
|
5,785 | $342,876 |
All Filings in TEVA
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,230,402 | 40,850 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,462,188 | 46,850 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $946,370 | 46,850 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,170,686 | 69,850 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,173,499 | 76,350 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,811,688 | 82,200 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,481,244 | 82,200 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,335,750 | 82,200 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,159,842 | 82,200 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $858,168 | 82,200 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $838,440 | 82,200 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $618,966 | 82,200 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $727,470 | 82,200 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $606,480 | 66,500 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $439,411 | 54,450 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $356,448 | 47,400 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $430,531 | 45,850 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $367,258 | 45,850 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $431,969 | 44,350 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $439,065 | 44,350 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $425,249 | 36,850 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $355,602 | 36,850 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $332,018 | 36,850 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||